Abstract:In the healthy brain, astrocytes play vital roles essential for neuronal transmission and blood–brain barrier (BBB) integrity. The transformation of astrocytes into reactive states constitutes a biological response of the central nervous system (CNS) to insults and changes in brain environment. It is well known that astrocytes can replicate and accumulate prions independently of neurons [1–5]. However, considerably less is known about the impact of their reactive transformation on neuronal function and neurodegeneration. In prion diseases, the beneficial role of reactive astrocytes appears to be linked to astrocyte-produced milk fat globule epidermal growth factor 8 (Mfge8), which facilitates the engulfment of apoptotic bodies and the clearance of cellular debris [6]. However, alongside the enhancement of protective functions, it is crucial to weigh potential deficits in homeostatic roles and the emergence of detrimental functions when evaluating the overall impact of reactive astrocytes on disease progression. Recent studies suggested that reactive astrocytes may exert a net negative impact on both neurons and endothelial cells. Reactive astrocytes isolated from prion-infected animals exhibit detrimental effects on primary neurons causing reduction in dendritic spine size and density along with impairment of synapse integrity [7] (Fig 1). The synaptotoxic effects were mediated by changes in the astrocytic secretome, highlighting the potential role of altered signaling pathways in neuronal dysfunction. In addition to their effects on neurons, reactive astrocytes disrupt the integrity of the BBB. Coculturing experiments involving astrocytes from prion-infected animals or exposure to conditioned media from reactive astrocytes induced a disease-associated phenotype in endothelial cells isolated from normal mice [8] (Fig 1). This phenotype was characterized by the down-regulation and aberrant localization of tight and adherens junction proteins, and an increase in permeability of endothelial layers. Notably, a very strong reverse correlation was observed between the degree of astrocyte activation and the incubation time to the prion diseases [9]. Animal groups with rapid disease progression exhibit more severe astrocyte reactivity, suggesting a potential link between phenotypic changes in astrocytes and disease severity. This observation brings up the possibility that phenotypic changes in reactive astrocytes contribute to the faster disease progression. Consistent with this hypothesis, inhibition of the unfolded protein response, which is exacerbated in reactive astrocytes, via selective targeting of PERK signaling, was found to prolong the incubation time to terminal disease in mice [10]. In summary, reactive astrocytes associated with prion diseases exhibit harmful effects on neurons and endothelial cells and are likely contributors to disease progression. Further elucidation of the underlying mechanisms driving astrocyte reactivity may hold therapeutic potential for mitigating neurodegenerative processes associated with prion diseases.

Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss

IκBα Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response Following Traumatic Brain Injury: Implications for Functional Recovery

Abnormal Activation of Microglia Accompanied with Disrupted CX3CR1/CX3CL1 Pathway in the Brains of the Hamsters Infected with Scrapie Agent 263K.

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Prion Peptide PrP106-126 Induces Inducible Nitric Oxide Synthase and Proinflammatory Cytokine Gene Expression Through the Activation of NF-κB in Macrophage Cells.

Neuroinflammation, Microglia, and Cell-Association during Prion Disease

RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection

Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism

Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia

Engulfment of viable neurons by reactive microglia in prion diseases

Reduction of NF-κB (p65) in Scrapie-Infected Cultured Cells and in the Brains of Scrapie-Infected Rodents.

Activation of Innate Immunity and Autophagy in Brain Tissues with Prion Disease and Degradation of Abnormal PrPs in Cells — China’s Studies

The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation

Stimulations of the Culture Medium of Activated Microglia and TNF-Alpha on a Scrapie-Infected Cell Line Decrease the Cell Viability and Induce Marked Necroptosis That Also Occurs in the Brains from the Patients of Human Prion Diseases

The NLRP3-Caspase 1 Inflammasome Negatively Regulates Autophagy via TLR4-TRIF in Prion Peptide-Infected Microglia

Toll-Like Receptor 2 Deficiency Shifts PrP106-126-Induced Microglial Activation from a Neurotoxic to a Neuroprotective Phenotype

Reactive astrocytes associated with prion disease impair the blood brain barrier

Reactive microglia partially envelop viable neurons in prion diseases

Reactive astrocytes in prion diseases: Friend or foe?

Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy

The Role of Glial Cells in Neurobiology and Prion Neuropathology